Yeah, NYR have played the simpletons and bagholders like Benny and Kyriaco for the raise pump, played them very well to their credit.
$25m MC for a preclinical mouse company with one lonely compound, no pipeline, history of failure, no IP protection, and a very dodgy NOX holding capping any moves, is frankly insane. And a sign that bio sector is perhaps overcooked now, once again....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.030(11.5%) |
Mkt cap ! $48.51M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 23.0¢ | $127.7K | 538.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 74050 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 55674 | 2 |
View Market Depth
| Last trade - 15.33pm 19/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |